Background: Information regarding the incidence and characteristics of COVID-19 pneumonia amongst pregnant women is scarce.
Methods: Single-centre experience with 32 pregnant women diagnosed with COVID-19 between March 5 to April 5, 2020 at Madrid, Spain.
Findings: COVID-19 pneumonia was diagnosed in 61·5% (32/52) women. Only 18·7% (6/32) had some underlying condition (mostly asthma). Supplemental oxygen therapy was required in 18 patients (56·3%), with high-flow requirements in six (18·7%). Eight patients (25·0%) fulfilled the criteria for acute distress respiratory syndrome. Invasive mechanical ventilation was required in two patients (6·2%). Tocilizumab was administered in five patients (15·6%). Delivery was precipitated due to COVID-19 in three women (9·4%). All the newborns had a favourable outcome, with no cases of neonatal SARS-CoV-2 transmission. Severe cases of pneumonia requiring supplemental oxygen were more likely to exhibit bilateral alveolar or interstitial infiltrates on chest X-ray (55·6% vs. 0·0%; P-value = 0·003) and serum C-reactive protein (CRP) levels >10 mg/dL (33·0% vs. 0·0%; P-value = 0·05) at admission than those with no oxygen requirements.
Interpretation: Pregnant women with COVID-19 have a high risk of developing pneumonia, with a severe course in more than half of cases. The presence of bilateral kung infiltrates and elevated serum CRP at admission may identify women at-risk of severe COVID-19 pneumonia.
Funding: Instituto de Salud Carlos III (COV20/00,181), Spanish Ministry of Science and Innovation.
Keywords: ALT, alanine aminotransferase; ARDS, acute respiratory distress syndrome; AST, aspartate aminotransferase; COVID-19; COVID-19, coronavirus disease 2019; CRP, C-reactive protein; CT, computerized tomography; Coronavirus; HCQ, hydroxychloroquine; ICU, intensive care unit; IFN-β, interferon-β; IMV, invasive mechanical ventilation; IQR, interquartile range; IV, intravenous; LPV/r, lopinavir/ritonavir; Pneumonia; Pregnancy; RT-PCR, reverse transcription polymerase chain reaction; Risk stratification; SARS-CoV-2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TCZ, tocilizumab; URTI, upper respiratory tract infection; ePaO2/FiO2, estimated arterial oxygen/fraction of inspired oxygen ratio.
© 2020 The Author(s).